PT81829A - Traegermatrix zur aufnahme von katalytisch wirkenden verbindungen und verfahren zur herstellung der traegermatrix - Google Patents

Traegermatrix zur aufnahme von katalytisch wirkenden verbindungen und verfahren zur herstellung der traegermatrix

Info

Publication number
PT81829A
PT81829A PT81829A PT8182986A PT81829A PT 81829 A PT81829 A PT 81829A PT 81829 A PT81829 A PT 81829A PT 8182986 A PT8182986 A PT 8182986A PT 81829 A PT81829 A PT 81829A
Authority
PT
Portugal
Prior art keywords
traigermatrix
traegermatrix
administration
production
catalytic compounds
Prior art date
Application number
PT81829A
Other languages
German (de)
English (en)
Other versions
PT81829B (pt
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of PT81829A publication Critical patent/PT81829A/pt
Publication of PT81829B publication Critical patent/PT81829B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
PT81829A 1985-01-14 1986-01-13 Novo processo para a preparacao de esteroides, especialmente de intermediarios para a preparacao de proligestona e compostos relacionados PT81829B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP85200022A EP0188010A1 (en) 1985-01-14 1985-01-14 New process for the preparation of certain steroids, especially intermediates for the preparation of proligestone and related compounds, and new intermediates formed in this process

Publications (2)

Publication Number Publication Date
PT81829A true PT81829A (de) 1986-02-01
PT81829B PT81829B (pt) 1987-11-30

Family

ID=8193986

Family Applications (1)

Application Number Title Priority Date Filing Date
PT81829A PT81829B (pt) 1985-01-14 1986-01-13 Novo processo para a preparacao de esteroides, especialmente de intermediarios para a preparacao de proligestona e compostos relacionados

Country Status (12)

Country Link
US (1) US5093502A (pt)
EP (2) EP0188010A1 (pt)
JP (1) JPS61172896A (pt)
AU (1) AU584158B2 (pt)
CA (1) CA1321576C (pt)
DE (1) DE3665721D1 (pt)
DK (1) DK14286A (pt)
ES (1) ES8707255A1 (pt)
GR (1) GR860072B (pt)
IE (1) IE58702B1 (pt)
NZ (1) NZ214798A (pt)
PT (1) PT81829B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6378196U (pt) * 1986-11-10 1988-05-24
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
AU5856090A (en) * 1989-07-07 1991-02-06 Endorecherche Inc. Androgen derivatives for use in the inhibition of sex steroid activity
DE69034035T2 (de) * 1989-07-07 2004-01-22 Endorecherche Inc., Ste-Foy Methode zur behandlung androgenbedingter krankheiten
KR950701527A (ko) * 1992-05-21 1995-04-28 라브리 페르낭 테스토스테론 5α 환원효소 활성 저해제(INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY)
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US20030022036A1 (en) * 2001-07-25 2003-01-30 Ballard Power Systems Inc. Fuel cell controller self inspection
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
NZ596876A (en) 2009-05-06 2014-01-31 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
CN106046099B (zh) * 2012-01-19 2018-03-16 华润紫竹药业有限公司 甾体化合物及其制备方法和用途
CN104628806A (zh) * 2012-01-19 2015-05-20 华润紫竹药业有限公司 甾体化合物及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3243355A (en) * 1965-07-30 1966-03-29 American Cyanamid Co Method of hydroxylating 19-nor-androstenedione
NL6703781A (pt) * 1967-03-13 1968-09-16
US3812105A (en) * 1968-09-11 1974-05-21 Koninklijke Gist Spiritus 19-nor-progesterone derivatives
GB1277886A (en) * 1968-09-11 1972-06-14 Koninklijke Gist Spiritus Androstenones
US4585591A (en) * 1980-12-10 1986-04-29 Mitsubishi Chemical Industries, Ltd. 17β-ethynylsteroids and process for preparing same
US4557867A (en) * 1984-01-25 1985-12-10 The Upjohn Company 11β-Difluoromethyl and (E)- and (Z)-11-fluoromethylene steriods
US4600538A (en) * 1984-08-02 1986-07-15 The Upjohn Company Corticosteroids from 17-keto steroids via 20-cyano-Δ17 (20)-pregnanes

Also Published As

Publication number Publication date
DK14286A (da) 1986-07-15
PT81829B (pt) 1987-11-30
IE860088L (en) 1986-07-14
DE3665721D1 (en) 1989-10-26
AU5225586A (en) 1986-07-17
NZ214798A (en) 1988-09-29
IE58702B1 (en) 1993-11-03
EP0188010A1 (en) 1986-07-23
EP0189951B1 (en) 1989-09-20
EP0189951A1 (en) 1986-08-06
ES8707255A1 (es) 1987-07-16
ES550862A0 (es) 1987-07-16
US5093502A (en) 1992-03-03
JPS61172896A (ja) 1986-08-04
AU584158B2 (en) 1989-05-18
DK14286D0 (da) 1986-01-13
CA1321576C (en) 1993-08-24
GR860072B (en) 1986-05-14

Similar Documents

Publication Publication Date Title
DE3670859D1 (de) Verfahren zur herstellung von organophiler kieselsaeure.
DE3671885D1 (de) Fliessbeton und verfahren zur herstellung von fliessbeton.
ATA348285A (de) Verfahren zur herstellung von suesswaren
DE3681966D1 (de) Oxydationskatalysatoren der perovskitgruppe und verfahren zur herstellung.
ATE66927T1 (de) Verfahren zur herstellung von chemisch definierten und reproduzierbaren polydeoxyribonukleotiden.
DE3650547T2 (de) Verfahren zur Herstellung von Halbleiterlasern
PT81829A (de) Traegermatrix zur aufnahme von katalytisch wirkenden verbindungen und verfahren zur herstellung der traegermatrix
PT81531A (de) Verfahren zur herstellung von isosilybinfreiem silibinin und araneimittel enthaltend silibinina
DE3681946D1 (de) Zahnfaeuleschutzpraeparate und verfahren zur herstellung derselben.
DE3650008T2 (de) Katalytische Zusammensetzung und Verfahren zur Herstellung von Silanen.
DE3671621D1 (de) Verfahren und vorrichtungen zur herstellung von glaskoerpern.
DE3679430D1 (de) Verfahren und vorrichtungen zur herstellung von glaskoerpern.
DE68928398D1 (de) Verfahren zur Herstellung von Polybuten
ATA96986A (de) Verfahren zur herstellung von epipodophyllotoxin und verwandten verbindungen
DE3650643D1 (de) Verfahren zur Herstellung von 3-Polyfluoroalkylisoxazolylaminen
DE204326T1 (de) Verfahren zur herstellung von l-threonin und l-isoleucin.
DE3673674D1 (de) Verfahren und vorrichtungen zur herstellung von glaskoerpern.
PT81841A (de) Traegermatrix zur aufnahme von katalytisch wirkenden verbindungen verfahren zur herstellung der traeger matrix
DE3672239D1 (de) Verfahren und vorrichtungen zur herstellung von glaskoerpern.
DE3675633D1 (de) Geraet und verfahren zur herstellung von steckverbindern.
ATE59634T1 (de) Verfahren zur herstellung von dialkyldisulfiden.
DE19675009I2 (de) Verfahren zur Herstellung von Hylan und Hylanverbindungen.
PT86452A (de) Verfahren zur herstellung der desmalonylverbindung von makrolid-lactonen
ATA268387A (de) Verfahren zur herstellung von azetidinonen
PT82393A (de) Verfahren zur herstellung von neuen benzoesaeurederivaten

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19941130